For citations:
Chazova I.E., Barbarash O.L., Kislyak O.A., Martynyuk T.V., Nedogoda S.V., Tkacheva O.N., Trushina O.I. The place of a new fixed combination Valsacor® INDA (valsartan and indapamide) in the treatment of patients with various phenotypes of arterial hypertension (resolution of the Council of Experts). Systemic Hypertension. 2025;22(3):43-47. (In Russ.) https://doi.org/10.38109/2075-082X-2025-3-43-47


























